Rite Aid Corporation (RAD)

21.67
NYSE
Prev Close 19.78
Day Low/High 19.74 / 23.18
52 Wk Low/High 8.86 / 22.45
Exchange NYSE
Shares Outstanding 55.22B
Market Cap 1.09B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Rite Aid Shares Tank on Reports FTC May Not Approve Deal With Walgreens

Rite Aid Shares Tank on Reports FTC May Not Approve Deal With Walgreens

Rite Aid shares are tanking on reports that the FTC may not approve Walgreens Boots Alliance's acquisition of the company.

Walgreens Misses Quarterly Revenue Estimates, Purchase of Rite Aid Is Pending

Walgreens Misses Quarterly Revenue Estimates, Purchase of Rite Aid Is Pending

A look at Walgreens Boots Alliance's latest quarterly results.

Dow Retreats From 20,000; Private Payrolls Rise by 153,000

Dow Retreats From 20,000; Private Payrolls Rise by 153,000

U.S. stocks were mixed on Thursday, with the Dow Jones Industrial Average retreating from the closely watched 20,000 level.

Dow 20,000 Slipping Further Away

Dow 20,000 Slipping Further Away

Tight trading ranges after a long advance, as we've had, often signals a downturn.

Go for Banks That Grow Their Book Value at a High Rate

Go for Banks That Grow Their Book Value at a High Rate

Owning such a bank can pay huge rewards to shareholders.

Rite Aid Misses Third-Quarter Expectations

Rite Aid Misses Third-Quarter Expectations

Rite Aid shares fell less than a point despite the earnings miss as it is in the process of being acquired by rival Walgreens.

Dow Closes In on 20,000; Rite Aid Shares Slip on Lackluster Results

Dow Closes In on 20,000; Rite Aid Shares Slip on Lackluster Results

Stocks fluctuate on Thursday, as investors kept a close eye on the Dow Jones Industrial Average as it nears the symbolic 20,000 threshold.

What to Watch Thursday: Third-Quarter GDP, Rite Aid Earnings

What to Watch Thursday: Third-Quarter GDP, Rite Aid Earnings

On Thursday investors await the final estimate of third-quarter gross domestic product, along with quarterly results from Rite Aid.

Cramer: Animal Spirits Are on the Prowl

Cramer: Animal Spirits Are on the Prowl

Things that once mattered in the market don't now.

Fred's Agrees to Acquire 865 Rite Aid Stores, Shares Soar

Fred's Agrees to Acquire 865 Rite Aid Stores, Shares Soar

Shares of Fred's were up big Tuesday after the company announced an agreement to purchase 865 Rite Aid stores.

Jim Cramer on Fred's Buying 865 Rite Aid Stores

Jim Cramer on Fred's Buying 865 Rite Aid Stores

Jim Cramer asks whether Fred's Pharmacy can succeed in buying hundreds of Rite Aid stores.

Stocks Inch Higher Despite Global Terror Attacks; Bank of Japan Leaves Policy Unchanged

Stocks Inch Higher Despite Global Terror Attacks; Bank of Japan Leaves Policy Unchanged

U.S. stocks inched higher Tuesday, with the Dow Jones Industrial Average closing in on 20,000, despite alleged terror attacks in Berlin, Zurich and Turkey on Monday

Cramer: Is Dow 20,000 the Market's Kryptonite?

Cramer: Is Dow 20,000 the Market's Kryptonite?

Every time the index nears that benchmark, the market's going to sell off.

Fred's Pharmacy Could Be Back in M&A Market

Fred's Pharmacy Could Be Back in M&A Market

Fred Pharmacy opted out of the Q&A session during its third quarter earnings call due to an undisclosed acquisition.

Cramer: This Despised Rally Has an Awful Lot Going for It

Cramer: This Despised Rally Has an Awful Lot Going for It

We have a host of positives that can and do seem to be playing out.

Cramer: Chicago Beats Cleveland, and I Don't Mean the World Series

Cramer: Chicago Beats Cleveland, and I Don't Mean the World Series

I'm talking about head-to-head comparisons of companies.

Cramer: Takeover Talks Drown Out Earnings Reports

Cramer: Takeover Talks Drown Out Earnings Reports

Prospective deals are hijacking an earnings-based focus on fundamentals.

British American Tobacco Will Need to Puff Up Reynolds Bid

British American Tobacco Will Need to Puff Up Reynolds Bid

British American Tobacco's $47 billion offer to purchase Reynolds American could face hurdles from shareholders as well as regulators.

Midday Report: Verizon Weighs on Dow; Crude Retreats From 2016 Best

Midday Report: Verizon Weighs on Dow; Crude Retreats From 2016 Best

U.S. stocks accelerate losses throughout the morning as crude oil retreats from its highest level of the year.

Cramer: Contested Election Could Mangle the Market

Cramer: Contested Election Could Mangle the Market

It would block the early November rally you'd expect when this big event is, at last, past us.

Morning Movers: DNKN, VZ, WBA, WFC, TSLA

Morning Movers: DNKN, VZ, WBA, WFC, TSLA

Walgreens extends merger deadline with Rite Aid, and Telsa unveils its new product.

Cramer: What a Democratic Sweep Would Mean for Stocks

Cramer: What a Democratic Sweep Would Mean for Stocks

For starters, trouble for banks, drugs, energy and M&A.

Midday Report: Intel Falls on Fourth-Quarter Weakness; Halliburton Swings to Profit

Midday Report: Intel Falls on Fourth-Quarter Weakness; Halliburton Swings to Profit

U.S. stocks edged higher on Wednesday after a stream of positive earnings trickled in.

Jim Cramer Will be Watching Walgreens Quarterly Report Thursday

Jim Cramer Will be Watching Walgreens Quarterly Report Thursday

Walgreens is set to report quarterly results on Thursday ahead of the opening bell and TheStreet's Jim Cramer believes the drugstore chain should walk away from Rite Aid.

Rite Aid Posts Better-Than-Expected Same-Store Sales; Merger With Walgreens Pending

Rite Aid Posts Better-Than-Expected Same-Store Sales; Merger With Walgreens Pending

Rite Aid shares are up Thursday after posting second quarter earnings of $0.03 a share, a penny ahead of forecasts.

U.S. Stocks Rise on Federal Reserve Inaction; Bed Bath & Beyond Posts Weak Results

U.S. Stocks Rise on Federal Reserve Inaction; Bed Bath & Beyond Posts Weak Results

U.S. stocks rose on Thursday, fueled by the Federal Reserve's decision Wednesday to keep interest rates lower for longer.

What to Watch on Thursday: Rite Aid Earnings, Existing Home Sales

What to Watch on Thursday: Rite Aid Earnings, Existing Home Sales

Earnings and economic data are in focus for Thursday, September 22.

Jim Cramer: Rite Aid Isn't Being Run Well

Jim Cramer: Rite Aid Isn't Being Run Well

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer isn't fond of how Rite Aid is being managed.

Markets Await Federal Reserve's September Statement This Week

Markets Await Federal Reserve's September Statement This Week

The Federal Reserve takes center stage for the week of September 19.

Here's What's Next for Walgreens

Here's What's Next for Walgreens

When bad news is good news.